statistiche ricercatore

Nome	#
Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?	104
BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides	97
Designing a ligand for pharmaceutical purposes	89
The perils of dental vacation: possible anaesthetic and medicolegal consequences.	87
ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents	78
How Druggable Is Protein Kinase CK2?	75
The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules	73
Transient abdominal motor block after a transversus abdominis plane block in an elderly patient	69
In silico binding free energy predictability by using the linear interaction energy (LIE) method: Bromobenzimidazole CK2 inhibitors as a case study	67
Carbazole-containing arylcarboxamides as BACE1 inhibitors.	66
Coumarin as attractive casein kinase 2(CK2) inhibitor scaffold: an integrated approach to elucidate the putative binding motif and explain structure-activity relationship.	61
Rational Design of New Protein Kinases Inhibitors of Pharmaceutical Interest	50
alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors	45
Totale	961

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	91	0	0	0	0	0	0	0	0	0	18	39	34
2019/2020	267	34	6	21	16	28	20	26	30	37	27	15	7
2020/2021	104	12	7	1	18	3	13	0	13	19	6	9	3
2021/2022	173	0	17	34	17	1	3	6	33	2	2	27	31
2022/2023	164	24	21	4	19	23	32	1	11	24	0	5	0
2023/2024	59	2	18	4	7	5	4	2	9	4	4	0	0
Totale													961